文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.

作者信息

Heatley Susan L, Sadras Teresa, Kok Chung H, Nievergall Eva, Quek Kelly, Dang Phuong, McClure Barbara, Venn Nicola, Moore Sarah, Suttle Jeffrey, Law Tamara, Ng Anthea, Muskovic Walter, Norris Murray D, Revesz Tamas, Osborn Michael, Moore Andrew S, Suppiah Ram, Fraser Chris, Alvaro Frank, Hughes Timothy P, Mullighan Charles G, Marshall Glenn M, Pozza Luciano Dalla, Yeung David T, Sutton Rosemary, White Deborah L

机构信息

Cancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.

Discipline of Medicine, University of Adelaide, SA, Australia.

出版信息

Haematologica. 2017 Dec;102(12):e490-e493. doi: 10.3324/haematol.2016.162925. Epub 2017 Sep 21.

DOI:10.3324/haematol.2016.162925
PMID:28935844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5709119/
Abstract
摘要

相似文献

[1]
High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.

Haematologica. 2017-12

[2]
Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options.

Semin Hematol. 2018-5-29

[3]
Xenograft-directed personalized therapy for a patient with post-transplant relapse of ALL.

Bone Marrow Transplant. 2016-9

[4]
Philadelphia chromosome-positive acute lymphoblastic leukemia in China: a retrospective study from the Chinese Childhood Cancer Group.

Leuk Lymphoma. 2016-11

[5]
Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia.

Haematologica. 2018-10

[6]
Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era.

Leuk Res. 2017-8

[7]
[Philadelphia chromosome-positive acute lymphoblastic leukemia relapsing with an anterior chamber lesion of the eye].

Rinsho Ketsueki. 2019

[8]
Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument "Pro".

Clin Lymphoma Myeloma Leuk. 2017-7

[9]
Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome.

Am J Hematol. 2003-11

[10]
T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy.

Pediatr Blood Cancer. 2017-3

引用本文的文献

[1]
Identification of Molecular Subtypes of B-Cell Acute Lymphoblastic Leukemia in Mexican Children by Whole-Transcriptome Analysis.

Int J Mol Sci. 2025-7-21

[2]
Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings.

Mol Diagn Ther. 2025-5

[3]
Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia.

Clin Exp Med. 2023-12

[4]
'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.

Br J Cancer. 2023-7

[5]
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.

Br J Cancer. 2022-9

[6]
Case Report: Precision Medicine Target Revealed by Modeling of Relapsed, Refractory Acute Lymphoblastic Leukemia From a Child With Neurofibromatosis.

Front Oncol. 2022-4-20

[7]
Prognostic value of CD20 antigen mediated immune checkpoint inhibition in patients with acute or chronic lymphocytic leukemia: A protocol for systematic review.

Medicine (Baltimore). 2022-2-18

[8]
Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.

Int J Mol Sci. 2022-3-2

[9]
Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature.

Cancers (Basel). 2021-11-19

[10]
Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.

Genes (Basel). 2021-5-1

本文引用的文献

[1]
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.

Blood. 2017-6-22

[2]
Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia.

Oncotarget. 2017-1-17

[3]
High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

J Clin Oncol. 2017-2

[4]
BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG/Erasmus MC and COG/St. Jude signatures.

Haematologica. 2015-9

[5]
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

N Engl J Med. 2014-9-11

[6]
Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.

J Clin Oncol. 2014-9-20

[7]
A revised definition for cure of childhood acute lymphoblastic leukemia.

Leukemia. 2014-12

[8]
Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual disease.

PLoS One. 2013-10-11

[9]
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

Blood. 2013-8-23

[10]
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.

Leukemia. 2013-2-14

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索